Lv21
130 积分 2023-10-27 加入
Advances in the treatment of systemic lupus erythematosus: Biologicals, small-molecular agents, and cell-depleting therapies coming to the clinic
4天前
已完结
A Novel Therapeutic Strategy for Sepsis: The Multiorgan Protective Properties and Clinical Potential of Ulineastatin
30天前
已关闭
Chronic myelomonocytic leukaemia
1个月前
已完结
Pre-Transplant MRD Negativity and Age Under 40 Predict Superior Long-Term Survival in Relapsed/Refractory B-ALL After CAR-T Therapy Bridging to Haploidentical HSCT: A Multicenter Retrospective Study With 6-Year Follow-Up
1个月前
已完结
Ulinastatin- and thymosin α1-based immunomodulatory strategy for sepsis: A meta-analysis
1个月前
已完结
Thymosin α1‐ and Ulinastatin‐Based Immunomodulatory Strategy for Sepsis Arising from Intra‐Abdominal Infection Due to Carbapenem‐Resistant Bacteria
1个月前
已完结
CD47 as a potent target in cancer immunotherapy: A review
2个月前
已完结
Management of relapsed/refractory DLBCL in the era of novel agents and new approaches
2个月前
已完结
Novel strategies to manage CAR-T cell toxicity
3个月前
已完结
皖公网安备34019202002308
